About
Basic Data Updated:
1 month agoThe Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 117.00 cr and a paid-up capital of Rs 116.50 cr, as per the Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Rohto Pharma (India) Private Limited India is Supreet Rekhi as Company Secretary. Keiji Nakajima, Koji Suzuki, and Daiki Kato serve as directors at the Company.
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24100HR2010FTC053292 |
| Company No. | 053292 |
| Company Classification | Private Limited Foreign Company Incorporated In India |
| Incorporation Date | 23 Sep 2010 |
| Date of AGM | 29 Dec 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Delhi |
Products or Services related to Rohto Pharma (India) Private Limited
HIV Drugs
Lip Cosmetics
Anti Cancer Medicines
Antidepressant & Anti Anxiety Medicines
Financials of Rohto Pharma (India) Private Limited
Rohto Pharma (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 96.33% decrease. The company also saw a substantial improvement in profitability, with a 81.17% increase in profit. The company's net worth observed a substantial decline by a decrease of 230.49%.
Corporate Structure
Unlock access to Rohto Pharma (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Rohto Pharma (India) Private Limited
Unlock and access historical data on people associated with Rohto Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (2)
Koji Suzuki
Managing DirectorAppointment Date: 23-Sep-2010
Status: Current
SR
Supreet Rekhi
Company SecretaryAppointment Date: 26-Mar-2024
Status: Current
Board Members(2)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rohto Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rohto Pharma (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Misaki Plastic Technologies Private Limited
Active
15 years 1 month Keiji Nakajima is a mutual person
Recent activity within the organization
Director Appointment
Supreet Kaur Rekhi was appointed as a Company Secretary was appointed as a Company Secretary on 26 Mar 2024 & has been associated with this company since 5 months 26 days .
26 Mar 2024Annual General Meeting
Rohto Pharma (India) Private Limited last Annual general meeting of members was held on 29 Dec 2023 as per latest MCA records.
29 Dec 2023Balance Sheet
Rohto Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
31 Mar 2023Director Appointment
Keiji Nakajima was appointed as a Director was appointed as a Director on 01 Apr 2021 & has been associated with this company since 3 years 5 months .
01 Apr 2021Director Appointment
Daiki Kato was appointed as a Director was appointed as a Director on 05 Aug 2020 & has been associated with this company since 4 years 1 month .
05 Aug 2020
Frequently asked questions
What is the Incorporation or founding date of Rohto Pharma (India) Private Limited?
